How much hospitals mark up some medicines by 250% on average?

Hospitals mark up some medicines by 250 % on average:

As Americans deal with the rising cost of prescription drugs, a new analysis found that some hospitals are raising prices for more than two dozen drugs by an average of 250 %, highlighting incentives to use more expensive branded treatments than lower-cost biosimilars. use. According to an analysis by Ronny Gal, a senior research analyst at Bernstein, hospitals show drug prices by an average of 250 percent. Stat examined data from 30 hospitals. Industry news also relates to Mark Cuba’s entry into generics, Teladoc’s emergence, and more.

The analysis used data from Centers for Medicare and Medicaid Services, which included the total costs and fees for all medicines from 3,792 hospitals. On average, these hospitals have increased the price of drugs by almost 500 percent, which corresponds to an analysis of 20 drugs previously conducted by Moran.

Markups on medicine prices often lead to higher reimbursement by health plans. More than half of commercial payers reimburse hospital outpatient departments as a percent of billed charges.

The analysis used Centers for Medicare and Medicaid Services data that included total costs and charges for all medicines from 3,792 hospitals. The price for a certain product can vary from one customer to the other, from one deal to another.

This blog does not provide medical advice. It is intended for informational purposes only. Do not use it as a
substitute for professional medical advice, diagnosis, treatment, or disease prevention. Always seek the
advice of your physician or qualified healthcare providers for any questions you have regarding a medical
The views and opinions expressed on this blog are solely those of the original authors and other
contributors. These views and opinions do not necessarily represent those of Gabriel Nieves, LAC
Healthcare Solutions, Staff, and/or any/all contributors to this blog/site.


Gabriel Nieves

After experiencing a variety of shortages, crises, and inefficiencies in the status quo of the procurement and distribution industry, I undertook the responsibility of building an interface for large organizations to abstract away uncertainty throughout their supply chain under most conditions.

We are focused on building a framework from which our teams of professionals on the ground can provide a new generation of procurement support and professional services for supply chain critical organizations around the nation.

We understand that the marketing process of critical supplies is a matter of national security and public safety. In this, we found our passion and mission: developing technologies, supplier networks, and platforms for the organizations that need it most.